CLINICAL SUPPLY MANAGEMENT ARTICLES
AI Is Only As Good As The Data Behind Your Clinical Trial Supply Chain
AI cannot fix bad clinical supply data. Disconnected systems, conflicting inventory and manual workarounds can turn smart forecasting into costly mistakes.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
Find out how advanced IRT systems now support diverse trial designs and how the expertise of RTSM vendors is crucial for tailoring solutions to trial needs and providing ongoing support.
-
Explore the ways technology suppliers across the clinical trial space have begun investing in IRTs built around a microservices model capable of improving data access and visibility.
-
Uncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.
-
Perhaps more than any other industry, pharma and biotech have undergone radical change over the past year, as a result of the COVID-19 pandemic. From supply chain security and capacity to clinical trial operations and site auditing, almost every aspect has been affected. Experts explore how these trends are shaping the industry and offer an outlook.
-
Data is the single most important thing in a clinical trial. Leverage the power of clinical trial data with effective utilization and access in a changing regulatory landscape.
-
Traditional clinical supply chains can't keep up. Learn how smart IRT platforms use real-time data to prevent shortages, cut waste, and keep trials running smoothly.
-
Which factors should you consider when selecting an IRT/RTSM vendor to ensure your trial's randomization and supply management processes are successfully executed?